NYSE · Price History

Novo Nordisk A/S (NVO) Stock Price History & Returns

$41.56 NYSE: NVO Market Cap $183.21B

Price history through Nov 13, 2026 · Source: Yahoo Finance (adjusted closes) (methodology)

How Novo Nordisk A/S (NVO) has performed, year by year and over each trailing period. Price history only — total return to a shareholder would also include dividends.

The share price of $41.56 sits 22% of the way up a 52-week range of $35.12 to $64.16; 35.2% below the 52-week high; above its 50-day moving average of $40.41; below its 200-day average of $43.48; a beta of 0.35 means it has historically moved less than the market.

Total return

Price change over each trailing period, not annualised.

PeriodReturn
3 months-8.1%
6 months-5.8%
1 year-11.1%
3 years-54.2%
5 years-19.8%

Year by year

32 of 45 years closed higher than the year before. Closes are the last observation in each calendar year.

YearCloseChange
2026$41.63-14.1%
2025$48.46-39.2%
2024$79.73-15.9%
2023$94.85+54.9%
2022$61.25+22.6%
2021$49.94+63.5%
2020$30.54+23.3%
2019$24.76+28.7%
2018$19.24-12.1%
2017$21.89+54.2%
2016$14.20-36.6%
2015$22.38+39.4%
2014$16.05+16.6%
2013$13.76+15.4%
2012$11.92+44.1%
2011$8.27+3.9%
2010$7.96+79.3%
2009$4.44+27.2%
2008$3.49-19.8%
2007$4.35+57.0%
2006$2.77+51.4%
2005$1.83+5.2%
2004$1.74+34.9%
2003$1.29+43.3%
2002$0.90-26.8%
2001$1.23+13.9%
2000$1.08+38.5%
1999$0.78-1.3%
1998$0.79-8.1%
1997$0.86+56.4%
1996$0.55+37.5%
1995$0.40+42.9%
1994$0.28+0.0%
1993$0.28+12.0%
1992$0.25+0.0%
1991$0.25+47.1%
1990$0.17+21.4%
1989$0.14+27.3%
1988$0.11+83.3%
1987$0.06-33.3%
1986$0.09+12.5%
1985$0.08+33.3%
1984$0.06-57.1%
1983$0.14+27.3%
1982$0.11+10.0%

Monthly closing prices

The last 36 months, newest first. 23 of 36 months closed higher than the month before. Each figure is the last close in that month.

MonthCloseChange
November 2026$41.63+2.4%
October 2026$40.65+7.2%
July 2026$37.91-19.9%
April 2026$47.34+30.4%
January 2026$36.29-25.1%
October 2025$48.46-8.3%
July 2025$52.85-18.7%
April 2025$65.01-0.6%
January 2025$65.40-18.0%
October 2024$79.73-27.8%
July 2024$110.37-16.3%
April 2024$131.81+11.2%
January 2024$118.57+25.0%
October 2023$94.85+13.8%
July 2023$83.38+12.9%
April 2023$73.83+1.7%
January 2023$72.60+18.5%
October 2022$61.25+35.8%
July 2022$45.09-10.1%
April 2022$50.16+0.3%
January 2022$49.99+0.1%
October 2021$49.94+16.7%
July 2021$42.81+15.2%
April 2021$37.15+24.2%
January 2021$29.90-2.1%
October 2020$30.54+0.6%
July 2020$30.36+6.9%
April 2020$28.41+8.8%
January 2020$26.12+5.5%
October 2019$24.76+11.9%
July 2019$22.12+2.2%
April 2019$21.64-2.4%
January 2019$22.18+15.3%
October 2018$19.24-2.3%
July 2018$19.69+3.3%
April 2018$19.07-6.4%

Novo Nordisk A/S (NVO) price history — frequently asked questions

How has Novo Nordisk A/S performed over the last year?

Novo Nordisk A/S (NVO) has fallen 11.1% over the last twelve months, measured on price alone.

What is Novo Nordisk A/S's five-year return?

Over five years the NVO share price has lost 19.8%, excluding dividends.

What is Novo Nordisk A/S's 52-week range?

Over the last year Novo Nordisk A/S (NVO) has traded between $35.12 and $64.16.

Price returns of other Drug Manufacturers - General stocks

LLY 1-year +42.2%JNJ 1-year +49.6%ABBV 1-year +30.8%MRK 1-year +63.7%NVS 1-year +25.4%AZN 1-year +5.2%AMGN 1-year +42.4%GILD 1-year +37.6%PFE 1-year +19.5%BMY 1-year +36.2%All Drug Manufacturers - General stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.